Procyon Biopharma Inc.
Proof-of-concept results of prostate cancer drug published in cancer journal
Published in Lab Business Week, September 5th, 2004
The article entitled "A Synthetic 15mer Peptide (PCK3145) Derived From Prostate Secretory Protein (PSP-94) Can Reduce Tumor Growth, Experimental Skeletal Metastases And Malignancy Associated Hypercalcemia" demonstrates the efficacy of PCK3145 in reducing tumor volume and delaying the development of skeletal metastases in a preclinical Mat Ly Lu model of prostate cancer.
Advanced late-stage prostate cancer usually results in spreading of metastatic cancer to the bone and subsequently leading to severe bone...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2004-09-05)
More Articles from Lab Business Week
- Advanced Viral Research Corp.
Third installment of $3 million dollars received for shares of biopolymer stock - Advancis Pharmaceutical Corp.
Pharmaceutical company reports loss of $0.37 per share - Aksys, Ltd.
Hemodialysis firm reports loss of $0.22 per share for second quarter - Alnylam Pharmaceuticals, Inc.
Pharmaceutical firm reports on IPO, financial results - Alpharma, Inc.
Pharmaceutical firm reports 5% decrease in revenues - Ambri Limited
Australian biotech firm reduces annual cash expenditure by 41% - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
